ANECORTAVE ACETATE FOR THE TREATMENT OF IDIOPATHIC PERIFOVEAL TELANGIECTASIA: A Pilot Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Retina

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.iae.0000244262.91018.4dPMID 16963851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Idiopathic Macular Telangiectasia

  2006cited by this paper
• Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.

  2003cited by this paper
• Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.

  2002cited by this paper
• Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

  2002cited by this paper
• The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

  2001cited by this paper
• Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis.

  1999cited by this paper
• Angiostatic Activity of Steroids in the Chick Embryo CAM and Rabbit Cornea Models of Neovascularization

  1999cited by this paper
• Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.

  1997cited by this paper
• AL-3789: a novel ophthalmic angiostatic steroid.

  1997cited by this paper
• Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization.

  1997cited by this paper
• Factors controlling ocular angiogenesis.

  1997cited by this paper
• Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

  1997cited by this paper
• Fibrovascular tissue in bilateral juxtafoveal telangiectasis.

  1996cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

  1993cited by this paper
• Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafoveolar retinal telangiectasis.

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis

  1993cited by this paper

• Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

  2022cites this paper
• Management of Idiopathic Macular Telangiectasia Type 2

  2019cites this paper
• Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature

  2017cites this paper
• Salient features and management options of macular telangiectasia type 2: a review and update

  2016cites this paper
• LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2

  2016cites this paper
• VEGF-Inhibition in Macular Telangiectasia Type 2

  2016cites this paper
• Treatment for Macular Telangiectasia Type 2.

  2016cites this paper
• Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

  2013cites this paper
• Macular telangiectasia type 2.

  2013cites this paper
• EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2

  2012cites this paper
• INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

  2011cites this paper
• The continuum of primary retinal telangiectasia.

  2011cites this paper
• Intravitreal bevacizumab therapy for idiopathic macular telangiectasia

  2010cites this paper
• Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia

  2009cites this paper
• The treatment of wet age-related macular degeneration.

  2009cites this paper
• LONG-TERM EFFECT OF INTRAVITREAL TRIAMCINOLONE IN THE NONPROLIFERATIVE STAGE OF TYPE II IDIOPATHIC PARAFOVEAL TELANGIECTASIA

  2008cites this paper
• Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia.

  2008cites this paper
• Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration.

  2008cites this paper
• Intravitreal bevacizumab treatment of retinal telangiectasis complicated by subretinal neovascularization.

  2008cites this paper
• Idiopathic Macular Telangiectasia

  2007cites this paper
• Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.

  2007cites this paper